Algert Global LLC Purchases 312,707 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Algert Global LLC raised its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 244.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 440,471 shares of the construction company's stock after purchasing an additional 312,707 shares during the quarter. Algert Global LLC owned 0.54% of Aspen Aerogels worth $5,233,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Sanders Morris Harris LLC lifted its holdings in shares of Aspen Aerogels by 337.5% in the 4th quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company's stock worth $436,000 after acquiring an additional 27,000 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Aspen Aerogels by 5.5% in the fourth quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company's stock worth $51,800,000 after purchasing an additional 226,251 shares during the last quarter. Barclays PLC increased its stake in Aspen Aerogels by 16.8% in the 4th quarter. Barclays PLC now owns 107,764 shares of the construction company's stock worth $1,280,000 after buying an additional 15,462 shares during the period. Swiss National Bank boosted its position in Aspen Aerogels by 1.9% in the 4th quarter. Swiss National Bank now owns 128,800 shares of the construction company's stock valued at $1,530,000 after buying an additional 2,400 shares during the period. Finally, MetLife Investment Management LLC grew its stake in Aspen Aerogels by 6.3% in the fourth quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock worth $425,000 after purchasing an additional 2,118 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. StockNews.com raised Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. B. Riley reduced their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research report on Wednesday, February 19th. Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a report on Friday, February 14th. Seaport Res Ptn lowered shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. Finally, Roth Mkm cut their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $19.11.

Aspen Aerogels Stock Up 14.8 %

Shares of ASPN stock traded up $0.64 during mid-day trading on Friday, reaching $4.95. 3,835,747 shares of the company were exchanged, compared to its average volume of 1,934,134. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The business's 50 day simple moving average is $6.08 and its 200 day simple moving average is $10.53. Aspen Aerogels, Inc. has a fifty-two week low of $4.16 and a fifty-two week high of $33.15. The company has a market capitalization of $406.42 million, a P/E ratio of 30.94 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01. The business had revenue of $78.72 million during the quarter, compared to the consensus estimate of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The business's revenue was down 16.7% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.02) earnings per share. Research analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.